The majority of αβ T cell subsets in AD were associated with enhanced capacity to produce both IL-17 and IL-22, whereas in control mice very few CD4+ or CD8+ αβ T cells were capable of IL-17 production, and even more constrained IL-22 secretion was evident (Figure 2D). The gene discussed is CD8A; the disease is Alzheimer disease.